Home » Topics » Conferences

Conferences
RSS

Dual 5alpha-reductase type I/II inhibitor from Lilly for prostatic cancer

May 12, 1997

Lilly prepares raloxifene analogs that reverse MRP-mediated resistance

May 12, 1997

Retinoid-like compounds that induce apoptosis in cancer cells

May 12, 1997

Glycan-conjugated 5-FU for the treatment of hepatocellular cancer/metastases

May 12, 1997

Taiho discovers potent and selective cdc25PTP inhibitors

May 12, 1997

Parke-Davis develops new c-src TK inhibitors

May 12, 1997

RPR selects farnesyltransferase inhibitor for in vivo evaluation

May 12, 1997

Schering-Plough evaluates novel farnesyltransferase inhibitor

May 12, 1997

TAS-103 shows antitumor activity against orthotopically implanted human cancers

May 12, 1997

In vivo efficacy and pharmacokinetic profile of XR-9051

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...